Skip to content
SurgCritCare
Dashboard

Analgesia / Sedation

Analgesia & Sedation in the Surgical ICU

Pain, agitation, and delirium management (PADIS) in the surgical ICU: analgesia-first approach, RASS sedation targets, SAT/SBT protocols, and multimodal pain strategies.

Source
SCCM PADIS Guidelines 2018
Status
review pending
Updated
5/29/2026
On this page
On this page

Content Status

Guideline-supported example educational content* based on SCCM PADIS Guidelines (2018). Drug selection, dosing, and protocols are...
Section
  • Guideline-supported example educational content* based on SCCM PADIS Guidelines (2018). Drug selection, dosing, and protocols are institution-specific. Always follow institutional order sets and attending guidance.
The SurgCritCare. org Analgesia page had no extractable clinical content at the time of access (navigation/shell only). This content is based on SCCM PADIS Guidelines.

Core Principle: Analgesia First

Address pain first before titrating sedation. Undertreated pain drives agitation and delirium.
Section

Address pain first before titrating sedation. Undertreated pain drives agitation and delirium.

Pain Assessment

Tool • Use Case • NRS (0–10)
Section
ToolUse Case
NRS (0–10)Patients who can self-report
CPOTPatients unable to self-report
BPSMechanically ventilated patients

RASS — Richmond Agitation Sedation Scale

Score • Label • Description
Section
ScoreLabelDescription
+4CombativeViolent, immediate danger to staff
+3Very agitatedPulls/removes tubes
+2AgitatedFrequent purposeless movement
+1RestlessAnxious, not aggressive
0Alert and calm
−1DrowsyEye opening > 10 sec
−2Light sedationBrief awakening < 10 sec
−3Moderate sedationMovement/eye opening, no contact
−4Deep sedationNo response to voice
−5UnarousableNo response to any stimulus
  • Target for most ventilated patients: RASS −1 to 0*

SAT / SBT — Wake and Breathe Protocol

SAT (Spontaneous Awakening Trial):* • Daily interruption of continuous sedatives/opioids • Safety screen first (no seizures, no...
Section
  • SAT (Spontaneous Awakening Trial):*
  • Daily interruption of continuous sedatives/opioids
  • Safety screen first (no seizures, no agitation requiring sedation, no FiO₂ escalation, no increasing vasopressors)
  • SBT (Spontaneous Breathing Trial):*
  • Pair with SAT
  • Pressure support ≤ 8 cmH₂O, PEEP ≤ 5 cmH₂O for 30–120 min
  • Extubate if trial passes

Common Sedation Agents

Agent • Class • Notes
Section
AgentClassNotes
FentanylOpioidPrimary analgesic; short-acting
PropofolSedativeTitratable; monitor for propofol infusion syndrome
DexmedetomidineAlpha-2 agonistLess delirium vs. benzos; preserves arousability
Lorazepam/MidazolamBenzodiazepinesAvoid/minimize — associated with delirium
KetamineNMDA antagonistAnalgesic; preserves airway; useful adjunct

Multimodal Analgesia

Scheduled acetaminophen, NSAIDs (if not contraindicated) • Regional/neuraxial analgesia • Ketamine adjunct
Section
  • Scheduled acetaminophen, NSAIDs (if not contraindicated)
  • Regional/neuraxial analgesia
  • Ketamine adjunct
  • Gabapentin/pregabalin (selective use)
  • Guideline-supported example educational content based on SCCM PADIS Guidelines 2018. Do not use without attending guidance and institutional review.*
Open source document